Table 3.

Major adverse events of study participants.

	Group SR N = 124	Group paAF N = 76	Group peAF N = 105	P-value
All-cause death, n (%)	0	2 (2.6)	2 (1.9)	NS
Hospitalization, n (%)	10 (8.1)	14 (18.4)	20 (19.0)	NS
Stroke, n (%)	0	1 (1.3)	3 (2.9)	NS
AF recurrence, n (%)	0	6 (7.9)	5 (4.8)	NS*
HF, n (%)	10 (8.1)	11 (14.5)	30 (28.6)	P < 0.05#,*

HF, heart failure; AF, atrial fibrillation; NS, no significance; NS^*, no significance between the Group paAF and the Group peAF.

^#P < 0.05, P-value between the Group SR and the Group paAF.

^*P < 0.05, P-value between the Group paAF and the Group peAF.

P < 0.05, overall.